Apures Co., Ltd. (XKON:149300)

Market Cap	363.89M -95.8%
Revenue (ttm)	517.33M -0.1%
Net Income	-3.73B
EPS	-138.55
Shares Out	45.49M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,756,923
Average Volume	240,668
Open	10.00
Previous Close	n/a
Day's Range	6.00 - 10.00
52-Week Range	6.00 - 248.00
Beta	-0.44
RSI	16.48
Earnings Date	n/a

About Apures

Apures Co., Ltd. engages in the development and commercialization of solutions for the bio and medical industries in South Korea. It is involved in the development of MICROPIG, which are research and laboratory mini pig species to provide solutions through standardization of biomaterials for medical experiments and development of regenerative medicine treatments, including cell therapy and heterogeneous organs. The company provides Porcine Primary Cell for in vitro test. It also manufactures and supplies Bio Membrane under the FCM brand, which ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2001
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 149300